Multifunctional nanoagent for thrombus-targeted fibrinolytic therapy

AIMS: Current thrombolytic therapies rely upon exogenous plasminogen activators (PA) to effectively lyse clots, thereby restoring blood flow and preventing tissue and organ death. Yet, these PAs may also impair normal hemostasis which may lead to life-threatening bleeding, including intracerebral he...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: McCarthy, Jason R., Sazonova, Irina Y., Erdem, S. Sibel, Hara, Tetsuya, Thompson, Brian D., Patel, Purvish, Botnaru, Ion, Lin, Charles P., Reed, Guy L., Weissleder, Ralph, Jaffer, Farouc A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2012
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3360120/
https://ncbi.nlm.nih.gov/pubmed/22348271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/nnm.11.179
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller